| Views | |
|---|---|
| Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies | 474 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies | 9 | 63 | 13 | 31 | 17 | 9 | 6 |
| Views | |
|---|---|
| 2019_Diedrichs_etal.pdf | 293 |
